Richard Newcomb
Impact in
-
- Cancer survivorship and care
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Neurology top 10%
- Long-Term Effects of COVID-19
Papers in
- Oncology 33
- Cancer survivorship and care 26
- CAR-T cell therapy research 5
- Hematology 12
- Hematopoietic Stem Cell Transplantation 8
- Co-authors
- Areej El‐JawahriRyan David NippSara MillerClayton T. CowlLaura E. BreeherSteven L. HigginsM. Hassan MuradGreg Vanichkachorn
- Journals
- Journal of Clinical Oncology (9 papers)Transplantation and Cellular Therapy (9 papers)Blood Advances (6 papers)Journal of the National Comprehensive Cancer Network (4 papers)Blood (4 papers)
- Partner nations
- United StatesAustraliaIsrael
In The Last Decade
Richard Newcomb
37 papers receiving 514 citations
Peers
Comparison fields: 5 of 83
- Oncology 226
- Neurology 122
- Geriatrics and Gerontology 28
- Critical Care and Intensive Care Medicine 33
- Pediatrics, Perinatology and Child Health 95
Countries citing papers authored by Richard Newcomb
This map shows the geographic impact of Richard Newcomb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Newcomb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Newcomb more than expected).
Fields of papers citing papers by Richard Newcomb
This network shows the impact of papers produced by Richard Newcomb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Newcomb. The network helps show where Richard Newcomb may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard Newcomb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 5 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 20 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 8 | |
| 10 | 2024 | 5 | |
| 11 | 2023 | 24 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 10 | |
| 14 | 2023 | 3 | |
| 15 | 2023 | 5 | |
| 16 | 2023 | 1 | |
| 17 | 2023 | 9 | |
| 18 | 2022 | 8 | |
| 19 | 2021 | 3 | |
| 20 | 2020 | 32 |
About Richard Newcomb
Richard Newcomb is a scholar working on Oncology, Hematology, Geriatrics and Gerontology, Pediatrics, Perinatology and Child Health and Transplantation, having authored 49 papers that have together received 522 indexed citations. Recurring topics across this work include Cancer survivorship and care (26 papers), Childhood Cancer Survivors' Quality of Life (16 papers), Palliative Care and End-of-Life Issues (13 papers), Hematopoietic Stem Cell Transplantation (8 papers), Family Support in Illness (6 papers), CAR-T cell therapy research (5 papers), Frailty in Older Adults (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). The work is most often cited by research in Oncology (226 citations), Neurology (122 citations), Geriatrics and Gerontology (28 citations), Critical Care and Intensive Care Medicine (33 citations) and Pediatrics, Perinatology and Child Health (95 citations). Richard Newcomb has collaborated with scholars based in United States, Australia and Israel. Frequent co-authors include Areej El‐Jawahri, Ryan David Nipp, Sara Miller, Clayton T. Cowl, Laura E. Breeher, Steven L. Higgins, M. Hassan Murad, Greg Vanichkachorn, Jennifer S. Temel and Joseph A. Greer. Their work appears in journals such as Journal of Clinical Oncology, Transplantation and Cellular Therapy, Blood Advances, Journal of the National Comprehensive Cancer Network and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.